The term innovation is all too often associated with market leading technology companies like Apple, Microsoft, Facebook, and Google.
News & Press Releases
Big things are happening.
News & Press Releases
News
Today's Medical Developments
Medical Device Start-Ups: Powering Paradigm Shifts in Product Design, Functionality, and Performance
AnnArbor.com
Michigan medical device spinoff Tangent Medical Technologies awarded sweeping patent for new IV catheter
After receiving Food and Drug Administration approval for its NovaCath short peripheral intravenous catheter and closing on an $8.6 million round of funding, the company announced Wednesday the issuance of a U.S. patent for the new device that covers a range of incorporated technologies.
AnnArbor.com
Nominees for AnnArbor.com Business Review's 2012 Deals of the Year
The black-tie ceremony, taking place Nov. 2 at Eastern Michigan University’s Student Center, honors the business decisions that had the most impact in the region over the previous year.
Plastic News
FDA clears IV catheter system
A new IV catheter system designed to minimize the risk of needle-stick injuries and occupational exposure to blood has received market clearance from the Food and Drug Administration.
Becker's ASC
Tangent Medical Receives FDA Clearance for IV Catheter System
Tangent Medical has announced it has received FDA clearance for a new IV catheter system.
TMD
FDA Clearance for the Next Generation Technology Addressing IV Therapy Challenges for Clinicians & Patients
Tangent Medical's NovaCath Secure IV Catheter System, a product designed to set new standards in peripheral IV catheter design, functionality, and performance, received FDA 510(k) clearance.
medGadget.com
Tangent Shows Off NovaCath Secure IV Catheter
Tangent Medical out of Ann Arbor, MI recently unveiled its NovaCath Secure IV Catheter System, a device designed to improve peripheral IV catheter stabilization and reduce the potential for clinicians being exposed to patient blood.
AnnArbor.com
People & achievements in the greater Ann Arbor area
Ann Arbor-based Tangent Medical, a developer and provider of IV therapy products, on April 12 announced submission of a 510(k) for its NovaCath Secure IV Catheter System, developed from extensive clinical research of health care worker and patient needs.
AnnArbor.com
Jeff Williams announced as new CEO of Ann Arbor-based Tangent Medical Technologies
Jeff Williams, a successful entrepreneurial executive in the Ann Arbor region, is the new CEO of Ann Arbor-based Tangent Medical Technologies, Inc., the company announced Thursday.
Medical Device Daily
Ann Arbor looking to foster innovation in medical technology
Tangent Medical Technologies was formed in July 2009. It has exclusive worldwide rights to Novacath, a patent-pending stabilized catheter system for peripheral intravenous (IV) fluid delivery that utilizes a simple built-in strain relief mechanism for improved stability.
MichBio.com
Member Profile of Tangent Medical Technologies, Inc.
Tangent’s patent-pending Novacath™ represents the next generation of peripheral IV devices. Unlike conventional IVs with add-on securement devices, Novacath™ is a complete peripheral IV system with built-in stabilization, by design.
AnnArbor.com
University of Michigan spinoff Tangent Medical Technologies developing new IV device
The poor performance of typical intravenous (IV) drug delivery systems prompted three University of Michigan researchers to pursue a new technological solution to the routine medical process. Their innovation became Tangent Medical Technologies Inc., one of two startup companies created by fellows from U-M’s Medical Innovation Center.
University of Michigan
New medical device company evolves from the U-M Medical Innovation Center
Tangent Medical Technologies, Inc. geared to improving safety of IVs used for hospitalized patients, reached licensing agreement with U-M for latest product.
Press Releases
Tangent Medical Named Finalist in 2013 American Business Awards
ANN ARBOR, MI – (May 15, 2013) - Tangent Medical (www.tangentmedical.com), an innovator in IV therapy products and creator of the NovaCath™ Integrated IV Catheter System, has been named a finalist in the American Business Awards, sponsored by the Stevie® Awards
Tangent Medical Announces the Five National Recipients of the 2013 Nurses’ Choice Awards
Ann Arbor, MI – (May 7, 2013) – Tangent Medical (www.tangentmedical.com), an innovator in IV therapy products and creator of the NovaCath™ Integrated IV Catheter System, this week is recognizing five nurses across the country with a 2013 Nurses’ Choice Awards.
Tangent Medical Announces 2013 Nurses’ Choice Awards Finalists
Ann Arbor, MI – (May 6, 2013) – Tangent Medical (www.tangentmedical.com), an innovator in IV therapy products and creator of the NovaCath™ Integrated IV Catheter System, today announced the finalists of the 2013 Nurses’ Choice Awards.
Tangent Medical Launches Nurses’ Choice Awards in Honor of National Nurses Week 2013
ANN ARBOR, MI – (April 16, 2013) - Tangent Medical Technologies (www.tangentmedical.com), an innovator in IV therapy products and creator of the NovaCath™ Integrated IV Catheter System, today launched an annual recognition program to promote excellence in nursing in conjunction with National Nurses Week 2013.
Tangent Medical Participates in Expert Panel Discussion at 18th Annual Medical Devices 2013: A Frost & Sullivan Executive MindXchange
ANN ARBOR, MI – (March 11, 2013) - Tangent Medical Technologies (www.tangentmedical.com), an innovator in IV therapy products and creator of the NovaCath™ Integrated IV Catheter System, announced its participation as a panelist at this year’s 18th Annual Medical Devices 2013 Frost & Sullivan Executive Conference at the Hilton San Diego. Tangent Medical Vice President of Sales & Marketing Curtis Bloch is one of five expert panelists for the session: Ask the Experts! Savvy Partnering for Innovation.
Tangent Medical Receives $8.6M in Venture Capital Funding
ANN ARBOR, MI – (February 2, 2013) - Tangent Medical Technologies (www.tangentmedical.com), an innovator in IV therapy products and creator of the NovaCath™ Integrated IV Catheter System, recently received $8.6M in a Series B round of funding led by Arboretum Ventures of Ann Arbor and Flagship Ventures of Cambridge, Mass.
Tangent Medical Named Most Innovative Company for the 2013 Business Excellence Awards
Tangent Medical (www.tangentmedical.com), an innovator in IV therapy products and creator of the NovaCath™ Integrated IV Catheter System, has been named the Most Innovative Company at the 2013 Business Excellence Awards announced recently by ActionCOACH, a leading business coaching firm sponsoring the award event.
Tangent Medical Named Finalist for the 2013 Business Excellence Awards
Tangent Medical (www.tangentmedical.com), an innovator in IV therapy products and creator of the NovaCath™ Secure IV Catheter System, today announced it has been named a Finalist for the Most Innovative Company in the 2013 Business Excellence Awards. The awards will be presented on January 25, 2013, during the Awards Night Event at the Business Excellence Forum.
Tangent Medical Announces Issuance of US Patent
Tangent Medical (www.tangentmedical.com), an innovator in IV therapy products, today announced the issuance of US Patent #8,323,249 for technology included in the NovaCath™ Secure IV Catheter System, a product designed to set new standards in peripheral IV catheter design, functionality and performance.
Tangent Medical Receives FDA Clearance for the NovaCath™ Secure IV Catheter System
Tangent Medical, an innovator in IV therapy products, today announced it has received FDA 510(k) clearance for the NovaCath™ Secure IV Catheter System, a product designed to set new standards in peripheral IV catheter design, functionality and performance.
Tangent Medical To Attend 2012 ENA Annual Conference in San Diego
Company Will Showcase the NovaCath Closed IV Catheter System to Address IV Therapy Challenges
Tangent Medical to Attend 2012 INS Annual Convention & Industrial Exhibition
Tangent Medical, an innovator in IV therapy products, today announced its participation (Booth # 329) at the 2012 INS Annual Convention & Industrial Exhibition on April 30 - May 2, 2012 at the Rio Hotel in Las Vegas. The NovaCath™ Secure IV Catheter System, currently under 510(k) review with the FDA, will be unveiled to the public for the first time at this convention. NovaCath is a next-generation technology designed to address current IV therapy challenges including catheter stabilization, occupational exposure to blood, tubing management and patient comfort.
Tangent Medical Submits FDA 510(k) For NovaCath™ Secure IV Catheter System
Tangent Medical, an innovator in IV therapy products, today announced submission of a 510(k) for its NovaCath™ Secure IV Catheter System, developed from extensive clinical research of healthcare worker and patient needs. This new closed IV catheter system is a next-generation technology designed to address several complex IV therapy challenges including catheter stabilization, occupational exposure to blood, and patient discomfort. When cleared by the FDA, the NovaCath™ system will be the first safety IV catheter offering advanced catheter stabilization technology designed to exceed the highest CDC, OSHA, and INS standards for peripheral IV catheter stabilization.
Tangent Medical Closes $4.5 Million Series A Financing
Tangent Medical Technologies, Inc., a development stage medical device company, announced the completion of a $4.5 million Series A equity financing co-led by Arboretum Ventures (Ann Arbor, MI) and Flagship Ventures (Cambridge, MA). Also participating in the financing were Osage Ventures and several angel investors responsible for the initial seed funding for the company. In conjunction with the financing, Tim Petersen of Arboretum and Harry Wilcox of Flagship have joined Tangent’s board of directors.
Michigan Pre-Seed Capital Fund Reports Investments Totaling $2.5 Million in 2010
Tangent's patent-pending Novacath™ was created to address health and safety shortcomings of existing catheter stabilization products for peripheral intravenous (PIV) fluid/medication delivery systems.